Allergy Therapeutics plc (AIM:AGY)
6.80
+0.14 (2.10%)
Feb 21, 2025, 4:35 PM GMT+1
Allergy Therapeutics Employees
Allergy Therapeutics had 612 employees as of June 30, 2023. The number of employees decreased by 10 or -1.61% compared to the previous year.
Employees
612
Change (1Y)
-10
Growth (1Y)
-1.61%
Revenue / Employee
90.19K GBP
Profits / Employee
-65.71K GBP
Market Cap
324.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Allergy Therapeutics News
- 2 months ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 8 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 3 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz